#oncology innovation

Discover 3 curated intelligence briefings related to this specific topic.

The Precision Paradox: High-Tech Diagnostics Meet a Crumbling Frontline

A collision of extremes is unfolding in global health. As the NCCN expands molecular profiling for brain cancer and AI-driven tools like Talos scale rare disease diagnosis, rural populations are falling behind in basic screenings and drug-resistant fungi are doubling in US hospitals.

Read Analysis

Science & Health

Is the biological script finally being rewritten?

Recent breakthroughs in June 2026 reveal a decisive move from managing chronic disease to active cellular restoration, scaling across 1,300 active gene therapy programs globally.

Read Analysis

Science & Health

Three Approvals in Five Days: The ADC Velocity Problem

From ASCO 2026's rapid-fire approvals to India's new GMP facilities, the ADC landscape is no longer about discovery—it is about the brutal efficiency of scale.

Read Analysis